KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Pacific Biosciences Of California (PACB) over the last 4 years, with Q3 2025 value amounting to 13.66%.

  • Pacific Biosciences Of California's Return on Invested Capital fell 127900.0% to 13.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.66%, marking a year-over-year decrease of 127900.0%. This contributed to the annual value of 0.79% for FY2024, which is 3400.0% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Return on Invested Capital stood at 13.66% for Q3 2025, which was down 127900.0% from 9.02% recorded in Q2 2025.
  • Pacific Biosciences Of California's Return on Invested Capital's 5-year high stood at 0.28% during Q2 2022, with a 5-year trough of 13.66% in Q3 2025.
  • In the last 4 years, Pacific Biosciences Of California's Return on Invested Capital had a median value of 0.73% in 2024 and averaged 2.73%.
  • In the last 5 years, Pacific Biosciences Of California's Return on Invested Capital skyrocketed by 500bps in 2023 and then plummeted by -127900bps in 2025.
  • Over the past 4 years, Pacific Biosciences Of California's Return on Invested Capital (Quarter) stood at 0.44% in 2022, then rose by 5bps to 0.41% in 2023, then plummeted by -140bps to 0.99% in 2024, then crashed by -1280bps to 13.66% in 2025.
  • Its Return on Invested Capital was 13.66% in Q3 2025, compared to 9.02% in Q2 2025 and 2.75% in Q1 2025.